GILEAD SCIENCES, INC.
Top Portfolio Positions
6 positions ·
$2,117,784,503 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ACLX |
Arcellx, Inc.
Healthcare
|
6,720,803 | $771,682,600 | 36.44% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
31,424,760 | $678,774,816 | 32.05% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
16,707,477 | $501,224,310 | 23.67% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
4,505,391 | $125,024,600 | 5.90% | |
| KYTX |
Kyverna Therapeutics, Inc.
Healthcare
|
4,126,119 | $35,608,406 | 1.68% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
650,389 | $5,469,771 | 0.26% |
Portfolio Trend
5 quarters · across all stocks
Holdings in ACLX
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $771,682,600 | 6,720,803 | Shares | Sole | 2026-05-08 | |
| 2026-02-23 | $764,491,341 | 6,720,803 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $551,777,926 | 6,720,803 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $442,564,877 | 6,720,803 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $440,884,676 | 6,720,803 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $515,418,382 | 6,720,803 | Shares | Sole | 2025-02-13 | |
| No 13F history on record for this holder in this stock. | ||||||